Implication of mGlu5 receptor in the enhancement of morphine-induced hyperlocomotion under chronic treatment with zolpidem.

Shibasaki, Masahiro

Implication of mGlu5 receptor in the enhancement of morphine-induced hyperlocomotion under chronic treatment with zolpidem. [electronic resource] - European journal of pharmacology Sep 2014 - 360-7 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1879-0712

10.1016/j.ejphar.2014.06.001 doi


Animals
Calcium-Calmodulin-Dependent Protein Kinase Type 2--metabolism
Calcium-Calmodulin-Dependent Protein Kinase Type 4--metabolism
Cyclic AMP Response Element-Binding Protein--metabolism
GABA-A Receptor Agonists--pharmacology
Glutamate Decarboxylase--metabolism
Male
Mice
Mice, Inbred ICR
Morphine--pharmacology
Motor Activity--drug effects
Phospholipase C beta--metabolism
Phosphoproteins--metabolism
Prosencephalon--drug effects
Pyridines--pharmacology
RNA, Messenger--genetics
Receptors, GABA-A--metabolism
Receptors, Metabotropic Glutamate--antagonists & inhibitors
Receptors, N-Methyl-D-Aspartate--metabolism
Receptors, Opioid, mu--genetics
STAT3 Transcription Factor--metabolism
Time Factors
Tyrosine 3-Monooxygenase--metabolism
Zolpidem